Skip to main content
. 2020 Dec 21;21(24):9759. doi: 10.3390/ijms21249759
3D Three dimensional
α Alpha
β Beta
BMMNC Bone marrow mononuclear cells
BMP Bone morphogenetic protein
BMSC Bone marrow stromal/stem cells
Ca Calcium
CA Catechol
CA-CS/ZM Ca/cs hydrogel modified by zif-8 np at a medium (1.2 mg) composition
CAG Chitosan-agarose-gelatin
CaP Calcium phosphate
CD Cluster of differentiation
CFNS Craniofrontonasal syndrome
CFU-F Colony forming unit-fibroblast
CPC Calcium phosphate cement
CS Chitosan
CSO/H Chitosan oligosaccharide/heparin
Cu Copper
CXCL12 C-X-C Motif Chemokine Ligand 12
CXCR4 C-X-C Chemokine Receptor type 4
DBBM Deproteinized bovine bone mineral
DBM Demineralized bone matrix
DPSC Dental Pulp Stem Cells
ECM Extracellular matrix
EGF-R Epidermal Growth Factor Receptor
ELP elastin-like proteins
FDA Food and Drug Administration
HA Hydroxyapatite
hiPSC human derived induced pluripotent stem cells
HLA-DR Human Leukocytet Antigen-DR
hMSC Human mesenchymal stem cells
IGFBP5 Insulin-like Growth Factor Binding Protein 5
IGF-R Insulin-like Growth Factor Receptor
IL-10 Interleukin 10
K Potassium
Lrg5 Leucine Rich Repeat Containing G Protein-Coupled Receptor 5
Mg Magnesium
NGF-R Nerve Growth Factor Receptor
OI Osteogenesis Imperfecta
P Phosphorus
PAM Polyacrylamide
PDGF-R Platelet-Derived Growth Factor Receptor
PEG Poly(ethylene glycol)
PLGA Poly Lactic-co-Glycolic Acid
PRP Plasma rich plasma
PTH Parathyroid Hormone
PTH1R Parathyroid Hormone 1 Receptor
PVA Plyvinyl alcohol
RANKL Receptor Activator of Nuclear Factor-Kappa B
SiO2 Silicon dioxide
TCP Tri-calcium phosphate
TGA Therapeutic Goods Administration
Ti Titanium
TiO2 Titanium dioxide
TNFα Tumor Necrosis Factor alpha
VEGF Vascular Endothelial Growth Factor
ZA Zoledronic acid
ZIF-8 NP Zeolitic imidazolate framework-8 nanoparticle
Zn Zinc
ZnO Zinc oxide
ZrO2 Zirconium oxide